Published in AIDS Weekly, June 7th, 2004
The placebo-controlled trial is evaluating the vaccine at three escalating dose levels in 18 healthy adult volunteers. The trial, in conjunction with the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID), U.S. Department of Health and Human Resources, is being conducted at the WRAIR Vaccine Clinical Research Center in Rockville, MD under the direction of principal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.